Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

COPAXONE for Relapsing-remitting multiple sclerosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 48 adverse event reports in the FDA FAERS database where COPAXONE was used for Relapsing-remitting multiple sclerosis.

Most Reported Side Effects for COPAXONE

Side Effect Reports % Deaths Hosp.
Injection site pain 163 12.9% 0 4
Multiple sclerosis relapse 136 10.7% 2 31
Injection site reaction 116 9.2% 0 1
Injection site mass 69 5.4% 0 0
Injection site erythema 61 4.8% 0 2
Dyspnoea 58 4.6% 2 11
Death 50 3.9% 50 1
Drug ineffective 45 3.6% 0 5
Fatigue 42 3.3% 0 3
Pain 40 3.2% 1 6
Injection site swelling 36 2.8% 0 1
Multiple sclerosis 35 2.8% 0 4
Asthenia 33 2.6% 1 11
Injection site bruising 33 2.6% 0 1
Fall 31 2.4% 0 11

Other Indications for COPAXONE

Multiple sclerosis (792) Product used for unknown indication (35)

Other Drugs Used for Relapsing-remitting multiple sclerosis

OCRELIZUMAB (15,658) FINGOLIMOD (8,814) OFATUMUMAB (3,864) DIMETHYL (3,638) NATALIZUMAB (2,749) INTERFERON BETA-1A (2,058) GLATIRAMER (1,965) ALEMTUZUMAB (1,604) TERIFLUNOMIDE (1,320) RITUXIMAB (956)

Related Pages

COPAXONE Full Profile All Relapsing-remitting multiple sclerosis Drugs COPAXONE Demographics COPAXONE Timeline